Impact of donor hepatitis C virus on kidney transplant outcomes for hepatitis C positive recipients in the direct acting antiviral era: time to revise the kidney donor risk index?

INTRODUCTION: Kidneys from donors with hepatitis C (HCV) infection are traditionally considered to be at risk for poorer survival outcomes, as reflected in the KDPI. Modern direct acting antivirals (DAAs) may modify this risk. METHODS: Using UNOS data, HCV infected adult first time kidney transplant...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplantation
Main Authors: Cannon, Robert M., Locke, Jayme E., Orandi, Babak J., Anderson, Douglas J, Davis, Eric G., Mackelaite, Lina, Dave, Hitarth, Eng, Mary, Jones, Christopher M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7083245/
https://ncbi.nlm.nih.gov/pubmed/31517783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0000000000002949
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados